BREZTRI 160 ug/1 (Budesonide, Glycopyrrolate, and Formoterol Fumarate AEROSOL, METERED) 160 ug/1

BREZTRI 160 ug/1 is a combination inhaler containing budesonide, glycopyrrolate, and formoterol fumarate. It is designed for respiratory conditions, offering a convenient treatment option for managing symptoms. This metered aerosol inhaler is manufactured by AstraZeneca Pharmaceuticals LP in the USA.

Strength

160 ug/1

Pack Size

28 AEROSOL, METERED in 1 INHALER (0310-4616-39)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BREZTRI 160 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This combination inhaler works by reducing inflammation and relaxing the airways, making it easier to breathe. It is often prescribed for individuals who require a combination of bronchodilators and corticosteroids to manage their symptoms effectively. What is BREZTRI used for? It is typically used to improve lung function and reduce the frequency of exacerbations in COPD patients.

Side Effects

Common effects of BREZTRI 160 ug/1 may include throat irritation, hoarseness, and dry mouth. Some users might experience headaches or tremors. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider. The inhaler is designed to deliver medication directly to the lungs, which can help minimize systemic side effects.

Precautions & Warnings

BREZTRI 160 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to ensure effective and safe use. Patients with a history of heart conditions, high blood pressure, or thyroid problems should use this inhaler with caution. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

BREZTRI 160 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to discuss all current medications with a healthcare provider to avoid adverse interactions. Alcohol consumption should be moderated, as it may exacerbate some side effects. Additionally, this inhaler should not be used in conjunction with other long-acting beta-agonists without medical supervision.

Frequently Asked Questions

BREZTRI 160 ug/1 is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It helps reduce inflammation and relax the airways to improve breathing.

BREZTRI 160 ug/1 is administered via inhalation. Follow the instructions provided by your healthcare provider or the product label for proper use.

Common side effects may include throat irritation, hoarseness, dry mouth, headaches, and tremors. These effects are usually mild and temporary.

BREZTRI 160 ug/1 may interact with other medications, so it is important to discuss all current medications with a healthcare provider to avoid adverse interactions.

BREZTRI 160 ug/1 is designed for long-term use in the management of COPD. However, regular follow-ups with a healthcare provider are recommended to monitor its effectiveness and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.